These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33008633)

  • 1. Toxicity after adjuvant therapy for stage III uterine cancer.
    Chen LC; Huang Y; Hou JY; Khoury-Collado F; Melamed A; St Clair CM; Tergas AI; Hur C; Hillyer GC; Hershman DL; Wright JD
    Gynecol Oncol; 2020 Dec; 159(3):737-743. PubMed ID: 33008633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiation followed by chemotherapy is associated with improved overall survival in endometrial cancer.
    Sinha S; Lazar A; Lam A; Anderson EM; Chen LM; Hsu IJ; Yoshida EJ
    Gynecol Oncol; 2020 Oct; 159(1):30-35. PubMed ID: 32811681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant Breast Cancer: Feasibility, Safety, and Toxicity.
    Sherry AD; Mayer IA; Ayala-Peacock DN; Abramson VG; Rexer BN; Chakravarthy AB
    Clin Breast Cancer; 2020 Aug; 20(4):344-352.e1. PubMed ID: 32234364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
    van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA
    Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology.
    Ko EM; Brensinger CM; Cory L; Giuntoli RL; Haggerty AF; Latif NA; Aviles D; Martin L; Morgan MA; Lin LL
    Gynecol Oncol; 2020 Nov; 159(2):394-401. PubMed ID: 32800655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma.
    Onal C; Sari SY; Yildirim BA; Yavas G; Gultekin M; Guler OC; Akyurek S; Yildiz F
    J Gynecol Oncol; 2019 May; 30(3):e28. PubMed ID: 30887753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma.
    Wong AT; Rineer J; Lee YC; Schwartz D; Safdieh J; Weiner J; Choi K; Schreiber D
    Gynecol Oncol; 2016 Sep; 142(3):514-9. PubMed ID: 27421751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing of therapy in women with stage III endometrial carcinoma receiving adjuvant combination chemotherapy and radiation.
    Latham AH; Chen L; Hou JY; Tergas AI; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2019 Oct; 155(1):13-20. PubMed ID: 31395371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemoradiotherapy vs. radiotherapy alone in early-stage high-risk endometrial cancer: a systematic review and meta-analysis.
    Jingjing H; Rui J; Hui P
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):833-840. PubMed ID: 30720192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice patterns and survival in FIGO 2009 stage 3B endometrial cancer.
    Jou J; Charo L; Hom-Tedla M; Coakley K; Binder P; Saenz C; Eskander RN; McHale M; Plaxe S
    Gynecol Oncol; 2021 Nov; 163(2):299-304. PubMed ID: 34561099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.
    Sozen H; Çiftçi R; Vatansever D; Topuz S; Iyibozkurt AC; Bozbey HU; Yaşa C; Çali H; Yavuz E; Kucucuk S; Aydiner A; Salihoglu Y
    Aust N Z J Obstet Gynaecol; 2016 Apr; 56(2):199-206. PubMed ID: 26890292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
    Montes de Oca MK; Albright BB; Secord AA; Havrilesky LJ; Moss HA
    Int J Gynecol Cancer; 2021 Dec; 31(12):1549-1556. PubMed ID: 34725205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the National Cancer Database.
    Nieto K; Adams W; Pham N; Block AM; Grover S; Small W; Harkenrider MM
    Gynecol Oncol; 2018 Jan; 148(1):147-153. PubMed ID: 29129389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
    Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
    Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Treatment of Stage I-II Serous Endometrial Cancer: A Single Institution 20-Year Experience.
    Akingbade A; Fabi F; Cartes R; Tsui J; Alfieri J
    Curr Oncol; 2024 Jun; 31(7):3758-3770. PubMed ID: 39057149
    [No Abstract]   [Full Text] [Related]  

  • 16. A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.
    Dickson EL; Vogel RI; Gehrig PA; Pierce S; Havrilesky L; Secord AA; Dottino J; Fader AN; Ricci S; Geller MA
    Gynecol Oncol; 2015 Nov; 139(2):275-82. PubMed ID: 26348313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer.
    Goodman CR; Hatoum S; Seagle BL; Donnelly ED; Barber EL; Shahabi S; Matei DE; Strauss JB
    Gynecol Oncol; 2019 Apr; 153(1):41-48. PubMed ID: 30660345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.
    Veluswamy RR; Mhango G; Bonomi M; Neugut AI; Hershman DL; Aldridge MD; Wisnivesky JP
    Ann Am Thorac Soc; 2013 Dec; 10(6):622-8. PubMed ID: 24024700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Adjuvant Chemotherapy, Radiation Therapy, or Combined Modality Therapy and the Impact on Survival for Uterine Carcinosarcoma Limited to the Pelvis.
    Wong AT; Lee YC; Schwartz D; Lee A; Shao M; Han P; Choi K; Schreiber D
    Int J Gynecol Cancer; 2017 Jul; 27(6):1171-1177. PubMed ID: 28574930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.
    Chapman BV; Swanick CW; Ning MS; Allen PK; Soliman PT; Westin SN; Pardeshi V; Broaddus RR; Lu KH; Jhingran A; Eifel PJ; Klopp AH
    Gynecol Oncol; 2019 Jul; 154(1):22-28. PubMed ID: 31109659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.